>> Sponsored Symposia Qiagen

Print PDF

Monday, July 5, 2010
17:30-18:30

Evening Symposium organized by QIAGEN, Inc.

QIAGEN – THE LEADER IN HPV TESTING NOW AND IN THE FUTURE

Moderator:
Prof. Attila Lorincz, Molecular Medicine, The Wolfson Institute of Preventive Medicine,
Queen Mary University of London, United Kingdom

HPV testing in primary screening

Dr. Chris Meijer, Department of Pathology, Free University Hospital, Amsterdam, Netherlands

QIAGEN’s QIAensemble and careHPV platforms

Dr. James Godsey, North America R&D, Chair, Women’s Health Portfolio Team, QIAGEN Inc., USA

 

Learning Objectives:
  • To discuss the latest data from the POBASCAM trial on the implementation of high-risk HPV testing in primary cervical cancer screening in the Netherlands
  • To increase awareness of the QIAensembleTM primary screening platform and give an update on upcoming test menu, including HPV testing based on eHC® chemistry
  • To discuss careHPVTM, QIAGEN's HPV testing platform for developing countries